MEI Pharma
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	6/30/2022	6/30/2023	6/30/2024	6/30/2026	6/30/2027	6/30/2028
Revenue % change YoY	$40.69M N/A	$48.81M 19.94%	$65.29M 33.76%	Avg: $25M Low: $25M High: $25M avg. -61.71%	Avg: $25M Low: $25M High: $25M avg. 0%	Avg: $25M Low: $25M High: $25M avg. 0%
Net Income % change YoY	$-54.73M N/A	$-31.84M 41.83%	$17.77M 155.83%	Avg: $-24.71M Low: $-24.71M High: $-24.71M avg. -239.04%	Avg: $-10.39M Low: $-10.39M High: $-10.39M avg. 57.95%	Avg: $-10.39M Low: $-10.39M High: $-10.39M avg. 0%
EBITDA % change YoY	$-95.91M N/A	$-36.76M 61.66%	$26.38M 171.75%	Avg: $-19.16M Low: $-19.16M High: $-19.16M avg. -172.63%	Avg: $-19.16M Low: $-19.16M High: $-19.16M avg. 0%	Avg: $-19.16M Low: $-19.16M High: $-19.16M avg. 0%
EPS % change YoY	-$8.8 N/A	-$4.78 45.68%	$2.67 155.85%	Avg: -$3.71 Low: -$3.71 High: -$3.71 avg. -238.95%	Avg: -$1.56 Low: -$1.56 High: -$1.56 avg. 57.95%	Avg: -$1.56 Low: -$1.56 High: -$1.56 avg. 0%
Operating Expenses % change YoY	$116.18M N/A	$85.58M -26.33%	$50.75M -40.69%	Avg: $29.66M Low: $29.66M High: $29.66M avg. -41.54%	Avg: $29.66M Low: $29.66M High: $29.66M avg. 0%	Avg: $29.66M Low: $29.66M High: $29.66M avg. 0%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of -60.36% in 2026-2028.

We have gathered data from N/A analysts. Their low estimate is -24.71M, average is -24.71M and high is -24.71M.

Wall Street analysts forecast annual average revenue growth of -20.57% in 2026-2028.

We have gathered data from N/A analysts. Their low revenue estimate is $25M, average is $25M and high is $25M.

Wall Street analysts forecast annual average earnings growth of -60.33% in 2026-2028.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$3.71, average is -$3.71 and high is $-3.71.